Evofem Biosciences Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EVFM | AMGN | VRTX | BMY | GILD |
| Company | Evofem Biosciences Inc | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 0.0100 | 276.00 | 472.31 | 58.00 | 92.40 |
| High | 0.0100 | 276.28 | 472.33 | 58.05 | 94.65 |
| Low | 0.0095 | 270.58 | 460.74 | 56.62 | 91.94 |
| Last | 0.0100 | 273.41 | 468.29 | 56.65 | 92.38 |
| Change | unch | -2.34 | -0.93 | -1.47 | +0.04 |
| % Change | unch | -0.85% | -0.20% | -2.53% | +0.04% |
| Volume | 23,000 | 4,493,500 | 1,043,800 | 10,578,700 | 7,525,400 |
| 20-Day Average Volume | 695,910 | 4,643,255 | 1,337,380 | 9,797,375 | 7,208,460 |
| Previous Close | 0.0100 | 275.75 | 469.22 | 58.12 | 92.34 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0099 | 282.87 | 464.68 | 58.39 | 91.18 |
| 20-Day Raw Stochastic | 28.57% | 31.45% | 43.74% | 17.08% | 73.51% |
| 20-Day Relative Strength | 47.71% | 33.93% | 49.06% | 50.25% | 55.58% |
| Weighted Alpha | -77.43 | -8.22 | +11.33 | +18.42 | +24.53 |
| Today's Opinion | 80% Sell | 88% Sell | 8% Sell | 80% Buy | 100% Buy |
| Previous Opinion | 88% Sell | 72% Sell | 8% Sell | 88% Buy | 100% Buy |
| Last Month's Opinion | 24% Buy | 8% Buy | 88% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.04% since 12/04/24 | -1.74% since 12/04/24 | +0.93% since 12/04/24 | -2.95% since 12/04/24 | +0.86% since 12/04/24 |
| Low | 0.0095 on 12/11/24 | 270.58 on 12/11/24 | 456.86 on 12/06/24 | 56.62 on 12/11/24 | 90.50 on 12/09/24 |
| High | 0.0120 on 12/06/24 | 280.00 on 12/09/24 | 476.46 on 12/10/24 | 59.76 on 12/09/24 | 94.65 on 12/11/24 |
| 1-Month | |||||
| %Chg | -24.24% since 11/11/24 | -15.04% since 11/11/24 | -6.66% since 11/11/24 | -5.30% since 11/11/24 | -4.79% since 11/11/24 |
| Low | 0.0080 on 11/29/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 55.82 on 11/15/24 | 86.08 on 11/19/24 |
| High | 0.0150 on 11/20/24 | 321.22 on 11/12/24 | 508.04 on 11/12/24 | 60.68 on 11/25/24 | 96.84 on 11/12/24 |
| 3-Month | |||||
| %Chg | +11.11% since 09/11/24 | -17.14% since 09/11/24 | -1.36% since 09/11/24 | +16.59% since 09/11/24 | +14.13% since 09/11/24 |
| Low | 0.0080 on 11/29/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 47.76 on 09/12/24 | 81.57 on 09/13/24 |
| High | 0.0150 on 11/20/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -20.00% since 06/11/24 | -9.08% since 06/11/24 | -2.75% since 06/11/24 | +31.68% since 06/11/24 | +42.36% since 06/11/24 |
| Low | 0.0060 on 07/01/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 39.35 on 07/05/24 | 62.69 on 06/18/24 |
| High | 0.0155 on 07/17/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,134 | 148,224,736 | 120,837,752 | 117,877,648 | 115,080,200 |
| Shares Outstanding, K | 113,356 | 537,533 | 257,529 | 2,028,177 | 1,246,266 |
| Annual Sales | 18,220,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | 52,980,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 4,500,000 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | -2,370,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | -0.87 | 0.55 | 0.36 | 0.45 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.02 on 11/14/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/12/24 | 02/04/25 | 02/03/25 | 10/31/24 | 02/04/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 02/14/25 | N/A | 10/04/24 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.44 | 0.00 | 50.18 | 20.45 |